Kim EH, Keet CA, Virkud YV, Chin S, Ye P, Penumarti A, Smeekens J, Guo R, Yue X, Li Q, Kosorok MR, Kulis MD, Burks AW. Open-label study of the efficacy, safety, and durability of peanut sublingual immunotherapy in peanut-allergic children. J Allergy Clin Immunol. 2023 Jun;151(6):1558-1565.e6. doi: 10.1016/j.jaci.2023.01.036. Epub 2023 Feb 23. PMID: 36828080; PMCID: PMC10257751.
Kim EH, Bird JA, Keet CA, Virkud YV, Herlihy L, Ye P, Smeekens JM, Guo R, Yue X, Penumarti A, Qaqish B, Li Q, Kulis MD, Burks AW. Desensitization and remission after peanut sublingual immunotherapy in 1- to 4-year-old peanut-allergic children: A randomized, placebo-controlled trial. J Allergy Clin Immunol. 2024 Jan;153(1):173-181.e10. doi: 10.1016/j.jaci.2023.08.032. Epub 2023 Oct 10. PMID: 37815782; PMCID: PMC10872748.
Soller L, Williams BA, Mak R, Wong T, Erdle SC, Chomyn A, Tetreault B, Morrison K, Gaudet L, Chan ES. Safety and Effectiveness of Bypassing Oral Immunotherapy Buildup With an Initial Phase of Sublingual Immunotherapy for Higher-Risk Food Allergy. J Allergy Clin Immunol Pract. 2024 Feb 27:S2213-2198(24)00198-3. doi: 10.1016/j.jaip.2024.02.024. Epub ahead of print. PMID: 38423293.
.png)
